Good efficacy and safety of vedolizumab in Crohn’s disease and ulcerative colitis in a real-world scenario

BACKGROUND: Data on vedolizumab (VDZ) use in inflammatory bowel disease (IBD) patients are still limited. We aimed to assess the effectiveness and tolerability of VDZ in a real-life clinical scenario. METHODS: We retrospectively collected data of all consecutive IBD patients who started VDZ from Sep...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Therap Adv Gastroenterol
Päätekijät: Zingone, Fabiana, Barberio, Brigida, Compostella, Federico, Girardin, Giulia, D’Incà, Renata, Marinelli, Carla, Marsilio, Ilaria, Lorenzon, Greta, Savarino, Edoardo Vincenzo
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: SAGE Publications 2020
Aiheet:
Original Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7350040/
https://ncbi.nlm.nih.gov/pubmed/32695231
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756284820936536
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia